Progression-free survival effect sizes in randomized controlled trials of targeted cancer therapies with positive outcomes

Acta Haematologica · Published 2026-07-06 · DOI 10.1159/000553384

Free full text

Authors (5)

Wei Zhang, Wen Yan, Mengyun Chen, Robert Peter Gale, Junren Chen

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Zhang, W., Yan, W., Chen, M., et al. (2026). Progression-free survival effect sizes in randomized controlled trials of targeted cancer therapies with positive outcomes. Acta Haematologica. https://doi.org/10.1159/000553384

Related articles

• Future Directions in Allogeneic Stem Cell Transplantation in Acute Lymphoblastic Leukemia · Acta Haematologica · 2025 · Same journal
• Establishment and Evaluation of Prognostic Prediction Model for Diffuse Large B-Cell Lymphoma Patients Based on International Prognostic Index and FAT4, TP53 Mutation · Acta Haematologica · 2025 · Same journal
• Increased Prevalence of Thromboembolic Events in Patients with Congenital Dyserythropoietic Anemia Type I · Acta Haematologica · 2025 · Same journal
• Acta Haematologica in the Era of Artificial Intelligence · Acta Haematologica · 2026 · Same journal
• Diagnostic Pathways and Procedural Risk in Primary Central Nervous System Lymphoma: A Nationwide Analysis · Acta Haematologica · 2026 · Same journal
• Real-World Data on First Relapse in Multiple Myeloma: Treatment Patterns and Outcomes in Finland Using Automated Data Collection · Acta Haematologica · 2026 · Same journal
• Hans-Based Cell of Origin Is Not of Prognostic Significance in Diffuse Large B-Cell Lymphoma Patients: A Retrospective Single-Center Study Conducted in 326 RCHOP-Treated Patients · Acta Haematologica · 2025 · Same journal
• A Case Report of Tyrosine Kinase Inhibitor Interruption in a Patient with Multilineage Philadelphia-Positive Acute Lymphoblastic Leukemia · Acta Haematologica · 2026 · Same journal
• First Comprehensive Characterization of Lip Lymphoma: A Population-Based Study · Acta Haematologica · 2026 · Same journal
• International Prognostic Scoring System, Revised International Prognostic Scoring System, and Molecular International Prognostic Scoring System Had No Identical Prognostic Power Depending on Treatment in Myelodysplastic Syndromes · Acta Haematologica · 2026 · Same journal